FIS
FCPM III Services Portfolio holdings
AUM
$369M
This Quarter Return
-28.79%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$414M
AUM Growth
+$414M
(-30%)
Cap. Flow
+$8.65M
Cap. Flow
% of AUM
2.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
$6.92M |
| 2 |
Astria Therapeutics
ATXS
|
$5.07M |
Top Sells
| 1 |
ACHL
Achilles Therapeutics plc American Depositary Shares
ACHL
|
$2.75M |
| 2 |
Replimune Group
REPL
|
$594K |
Sector Composition
| 1 | Healthcare | 99.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NewAmsterdam Pharma
NAMS
$2.77B
| $224M | 54.11% |
10,935,310
+338,129
| +3% | +$6.92M |
|
2
Dyne Therapeutics
DYN
$1.92B
| $57.1M | 13.81% |
5,462,846
| – | – |
|
3
enGene Holdings
ENGN
$241M
| $43.2M | 10.43% |
9,632,561
| – | – |
|
|
4
Replimune Group
REPL
$455M
| $38.1M | 9.21% |
3,909,696
-60,972
| -2% | -$594K |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$519M
| $29.3M | 7.08% |
3,452,330
| – | – |
|
|
6
Astria Therapeutics
ATXS
$361M
| $20.4M | 4.93% |
3,822,537
+950,000
| +33% | +$5.07M |
|
|
7
enGene Holdings Inc. Warrants
ENGNW
$6.77M
| $1.73M | 0.42% |
2,878,148
| – | – |
|
|
ACHL
8
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| – | – |
-2,390,050
| Closed | -$2.75M |
|